Evidence appraisal
Check product identity, authorised claims, formulation, dose and populations. Deliver sources, applicability and gaps.
Acceptance: traceable claims with clear support and limitations.
Clients want sales growth; consumers need reliable purchasing information. EOS appraises health claims with sources and limits, applies them to agent answers, purchase pages and partner materials, then tests exposure, enquiries and paid conversion and follows trust, reputation and repeat purchases.
For nutrition, health devices, exercise and rehabilitation products, sleep services, and consumer goods with health or safety claims.

HEALTH BRANDS & SUPPLEMENTS · COMMERCIAL EVIDENCE DELIVERY
Clients want sales growth. EOS first appraises the evidence, then applies it to consumer comparisons, agent answers and partner diligence, and evaluates exposure, enquiries, payments and margin while following brand trust, reputation and repeat purchases.
FIRST DELIVERY · GLOBAL AGENT STRATEGY
Official mechanisms reviewed for eight major platforms, separating web retrieval, citations, product display and active tool integrations. EOS supplies trustworthy living evidence within a loop linking client products, channels and outcomes.
Archive existing claims, pages and channel performance.
Appraise evidence, create buying/partner materials, connect the product and measure.
Report exposure/conversion differences and follow trust, referrals and net repeat purchases.
Check product identity, authorised claims, formulation, dose and populations. Deliver sources, applicability and gaps.
Acceptance: traceable claims with clear support and limitations.
Turn reviewed evidence into FAQs, selection/comparison pages, product-page modules and partner briefs, mapped to sources and conditions.
Acceptance: accessible evidence and answers to agreed purchase questions.
Deliver fixed-query agent test logs, a concurrent conversion-pilot protocol and an outcome report covering enquiries, net purchases and incremental margin.
Acceptance: auditable records and definitions, whether results improve or not.
Evidence determines scientific findings; commercial pilots assess sales effects. Papers, evidence pages and integrations have distinct uses, and their contribution to actual purchasing needs measurement.
An initial rapid appraisal of seven human studies is available. Next, turn applicable evidence into consumer and partner materials, connect the official client product page, validate exposure, paid conversion and margin, and follow trust, referrals and repeat purchases.
Inspect global agent strategy and the commercial loopAppraise ingredients, products and complete programmes by actual identity and use context. Open a category for details; Libaorui also has an initial dossier-review case.
| Category | Examples | Customer question | Deliverables | Explore |
|---|---|---|---|---|
| Skincare & cosmetics | Moisturisers, sunscreens, anti-wrinkle products and beauty devices | Which skin types and goals are supported by finished-product evidence? | Claim matrix, ingredient and product evidence cards, skin-type applicability and comparison dossier. | View details |
| Food & beverages | Probiotic drinks, formulated foods, nutrition meals and meal replacements | Do formulation and intake match the studies and dietary needs? | Nutrition and claim checks, formulation appraisal, consumer FAQ and structured dossier. | View details |
| Sports nutrition foods | Endurance foods, energy gels, protein and recovery foods | What benefits are supported for which exercise context, dose and timing? | Exercise evidence cards, use conditions, product study design and channel materials. | View details |
| Health foods & supplements | Vitamins, minerals, fish oils and combination supplements | Which evidence informs consumer choice and produces verifiable enquiries and paid conversion? | Claim-to-evidence map, purchase FAQs and partner materials, agent discovery testing, controlled sales pilot and outcome report. | View details |
| Medicines & drug regimens | Prescription drugs, OTC medicines and combination regimens | What is the benefit for which patients compared with alternatives? | Benefit-risk matrix, applicability analysis, medical-affairs materials and traceable evidence library. | View details |
| Sports watches & wearables | Sports watches, heart-rate straps, sleep and recovery trackers | Are measurements accurate, and do they improve behaviour or outcomes? | Measurement matrix, context limits, algorithm-version dossier and user explanations. | View details |
| Exercise equipment & assistive robotics | Training robotic arms, smart gym equipment, exoskeletons and assistive devices | What benefit is added over standard training or existing equipment? | Performance-to-benefit evidence chain, comparison report, use contexts and channel materials. | View details |
| Medical devices & digital medical products | Implants, rehabilitation devices, diagnostics, medical software and digital therapeutics | Which model, intended use and population have credible clinical value? | Version-specific dossier, clinical-value report and procurement or payer appraisal materials. | View details |
| Psychological & behavioural interventions | Psychotherapy programmes, behaviour-change interventions, meditation and support apps | Which outcomes improve, for whom, and when is professional care needed? | Intervention evidence map, effect and applicability report, review plan and user guidance. | View details |
| Sleep, rehabilitation & health services | Sleep courses, exercise prescriptions, rehabilitation and combined health services | Does the programme work, and which components contribute? | Programme evidence matrix, delivery specification, outcome appraisal and study design. | View details |
Preprints are research entry points, product pages are transaction entry points, and evidence pages connect them. Choose from these deliverables by category and actual evidence; no completed study or integration is implied.
| Delivery | Asset | Discovery & purchasing role | Prerequisites & limits |
|---|---|---|---|
| Preprint paper | Full methods, results, limitations, conflicts and version history. | A citable research entry point for professional evaluation. | Requires actual reportable research; not peer reviewed, and acceptance depends on repository policy. |
| Peer-reviewed paper & product study | Registered protocol, controlled study, product results, data and report. | Strengthen product-specific evidence for professional partners and procurement. | Results may be negative; publication does not replace registration or communication permissions. |
| Public product evidence page | Stable URL, specific product version, evidence cards, sources, applicability and update date. | Provide readable sources for search and browsing agents and verifiable purchasing context. | Must be public, crawlable and readable; publication does not guarantee indexing or citation. |
| Context and product comparison pages | Compare dose, evidence, cost and limits by exercise context, skin type or goal. | Serve intent-driven searches and help users assess fit. | Use traceable comparisons, disclose commercial relationships and review category-specific wording. |
| Sourced FAQ & buying guide | Real questions, clear answers, sources, use conditions and unresolved findings. | Address purchasing uncertainty, reduce repetitive support and provide accurate agent-readable content. | Brand FAQs still require communication review; questions cannot disguise unsupported claims. |
| Product page & structured product data | Identity, specifications, price, stock, fulfilment, returns and valid purchase link. | Connect evidence to actual offers and reduce product and transaction information mismatch. | Structured data is not certification; evidence-extension fields may not be consumed by platforms. |
| Platform product feed | Supply and update catalogue, prices, availability and seller data to platform specifications. | Support platform discovery and accurate listings after access approval. | Check eligibility and category restrictions; prescription drugs cannot use ordinary product-discovery routes. |
| Evidence query API / MCP | Query sources, applicability, limitations and versions by product, population and outcome. | Provide current evidence and query records to integrated or authorised agents. | An endpoint is not automatic discovery; integration, permissions and answer evaluation are required. |
| Partner evidence pack & procurement brief | One-page brief, report, evidence table, product specifications and partner terms. | Support different buying processes across clubs, retail, professional services and hospitals. | Tailor to the channel and track prospects separately from purchases. |
| Open research materials & living updates | Search methods, study register, shareable data, versions and correction records. | Improve auditability and provide updated evidence for repeated use and purchasing. | Share only authorised materials; review full-text rights, personal data and confidential information. |
Evidence page, FAQ, comparison and partner brief. Explain the actual product and its evidence.
Improve product information, apply for eligible platform feeds or integrate one agent query endpoint.
Publish a preprint when actual research exists; run a controlled channel pilot measuring citations, qualified visits and sales.
Suggested measurement: public readability → indexing → correct citations → qualified visits → completed purchases. Measure each stage separately and use a concurrent control for conversion effects; publication volume is not sales impact.
Platform access requirements: OpenAI product feed documentation (checked 6 October 2026)
“Find health products that fit me. I have a limited budget and allergy restrictions. Compare evidence, use conditions and total costs.”
Our inference: as choices reflect personal circumstances, brands need claims, specifications, evidence and limits that can be checked together. This is a business thesis, not a published platform ranking rule.
Remembers goals and constraints, browses and compares options, with approval for sensitive actions. Brand information should answer contextual questions.
Official model explanationDiscovers products around budgets, preferences and constraints. ACP and product data support discovery; merchants can handle checkout.
Official model explanationUniversal Cart announced cross-merchant shopping context, price and stock monitoring, and compatibility checks. Availability depends on the platform.
Official model explanationConsumers control their personal-agent information and permissions. EOS proposes reviewable evidence content; platform access and recommendation effects require independent verification.
Connect “why does this fit me?” to product versions, relevant people, findings and sources. When evidence is insufficient, deliver an evidence-development plan and revised claims.
For people: page / PDF. For machines: CSV / JSON. The format does not imply platform indexing.
These are fictional requests and illustrative delivery structures, not completed client work, product-effect findings or platform recommendations.
Ingredient papers are cited, but buyers cannot tell whether they apply to this bottle.
“Compare three drinks: do the strains, serving doses, sugar and study populations match?”Separate ingredient information, product effects and unresolved evidence gaps.
| Check | Inputs required | Delivery interpretation |
|---|---|---|
| Ingredient research | Check strain, dose and population | Can explain the ingredient; appraise product effects separately |
| Product study | Match the sold version and outcomes | Record as pending when inputs are unavailable |
| Health claim | Locate original findings and limits | Bound the wording and prioritise evidence gaps |
The table illustrates appraisal methods without invented effect or sales data.
Filtration specifications and health claims are mixed, making like-for-like comparison difficult.
“For a child’s bedroom, compare noise, filter costs and relevant health evidence.”Connect performance, use conditions and health outcomes to their respective evidence.
| Check | Inputs required | Delivery interpretation |
|---|---|---|
| Filtration performance | Specific model and test report | Compare specifications under matching conditions |
| Ownership costs | Filters, replacement schedule and power assumptions | Calculate from explicit inputs; no invented values |
| Health outcomes | Match device, population and real-life use | Performance testing does not itself establish disease improvement |
The table illustrates appraisal methods without invented effect or sales data.
Testimonials and satisfaction exist, but outcomes and service scope are not consistently defined.
“Compare courses and wellbeing programmes: what is included, for whom, and how are results assessed?”Define the service and measurement framework, then plan the evidence required.
| Check | Inputs required | Delivery interpretation |
|---|---|---|
| Service content | Sessions, personnel and delivery cadence | Comparable service scope |
| Outcome appraisal | Measures, completion and follow-up | Analyse effects only when actual data are available |
| Professional boundaries | Eligible users and criteria for medical referral | Separate satisfaction from causal effects |
The table illustrates appraisal methods without invented effect or sales data.
Inspect the value and deliverables, then agree scope, review and fees.
Do ingredient, mechanism or category studies support this product?
Human-readable report and CSV; findings may support, partly support or not support a claim.
Agree start and delivery milestones after scoping; a claim may be unsupported, and fees buy the appraisal work.
Excludes efficacy certification, advertising legal review and product trials.
People and agents cannot easily verify or compare product evidence.
Page, PDF, CSV and JSON; check field-level sources, without a promise of platform recommendation.
Price claims, page, PDF/CSV/JSON and review together; agree maintenance cadence and limits separately.
Excludes platform integration, ranking, sales and certification guarantees.
Which evidence gap should the next research investment address?
Confirm study capabilities and collaboration; accept by protocol and actual records.
Accept design before deciding on execution; approve recruitment, testing and external costs first.
Excludes uncommissioned study execution and positive-result guarantees.
Amounts are proposed references or examples. Formal quotes depend on inputs, questions, professional review and acceptance scope. Agree updates separately; the same work is not charged twice.
Meta announced connections including Shopify, Stripe and Canva; publishing, sending and spending require user approval.
Read the official announcementThe personal agent can browse, fill forms and continue tasks, requesting approval before purchases. The announcement was updated on 30 September.
Read the official announcementGoogle announced a cart across its services, price and stock monitoring, and compatibility checks, with a US-first rollout plan.
Read the official announcementOpenAI expanded ACP to product discovery and data. Shopify Catalog supplies product information to ChatGPT, while merchants can use their own checkout.
Read the official announcementThe news records published industry developments. The role of evidence dossiers in purchasing is EOS’s business thesis. Launch plans are not presented as globally available features.
Fees cover retrieval, appraisal, research and delivery. Findings retain support, contrary evidence and uncertainty. Consumers and platforms independently determine recommendations and purchases; EOS offers no official platform certification or ranking guarantee.
Reference: ChatGPT product-selection guidanceShare the product version, intended health value, available evidence and target customers. Assess the inputs and addressable question, then agree deliverables and a quote.